Predictive Diagnostics

Mucopolysaccharidosis Type I Market Projected for Steady Growth

DelveInsight forecasts an 8% CAGR from 2025 to 2034, driven by improved diagnostics and expanding treatment options....

Europe Embraces Health Data Sharing as Johnson & Johnson MedTech Survey Shows Rising Trust in Tech-Driven Care

Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....

Altamont Integrates AI into Radiology Reporting

Seamless AI-powered reporting enhances speed and accuracy in clinical workflows...

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine

Amid growing global pandemic concerns, SK bioscience partners with South Korea's national effort to advance rapid-response vaccine development against avian influenza threats....

Accuray Marks Milestone with First CyberKnife® SRS/SBRT Treatments in Austria

Innovative radiosurgery system debuts at Ordensklinikum Linz, advancing precision cancer care in the region ...

Implantica Expands RefluxStop™ Access with New Center of Excellence in Spain

Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region. ...

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....

Royal Marsden First to Use RaySearch Adaptive Radiotherapy in Cancer Care

UK hospital becomes first globally to treat patient with new module for online adaptive radiotherapy ...

PureHealth Posts $137.6M Q1 Profit Under Chairman H.E. Kamal Al Maazmi and CEO Farhan Malik

Middle East's largest healthcare group posts solid growth across all segments, fueled by rising patient volumes, tech innovation, and global expansion...

Peter Arduini Leads GE HealthCare Into FY25 With 51% Net Income Growth and $1B Share Repurchase Amid Global Uncertainty

With strong U.S. demand, a robust radiopharma rollout, and 4% organic revenue growth, CEO Peter Arduini highlights precision care strategy and innovation as GE HealthCare revises guidance under tariff pressures....